Expert Call Transcripts
Primary research on demand. Every transcript is MNPI-screened, PII-redacted, and compliance-certified. No subscription — buy exactly what you need.
Analyzes Indian pharmaceutical distribution, highlighting fragmented multi-tier networks, credit-driven trade dynamics, margin structures, and continued dominance of traditional stockist-led supply chains despite emerging channels.
Explores the Indian digital health landscape, highlighting shifts toward preventive corporate health, teleconsultation limitations, diagnostics-led growth, and B2B2C models driving adoption and unit economics.
Analyzes UK travel insurance market, highlighting post-COVID claims volatility, medical inflation impact, portfolio segmentation strategies, and scenario-based approaches to managing systemic reserving risks.
Analyzes the biotech clinical trials ecosystem, highlighting CRO performance metrics, oncology-driven demand, Phase II–III bottlenecks, and shift toward unified digital platforms improving efficiency and data management.
Explores biopharma market dynamics, highlighting biologics growth, AI's role in drug discovery, CDMO concentration, and clinical trial bottlenecks limiting commercialization success rates.
Analyzes healthcare lending lifecycles in India, including automation across underwriting, NBFC partnerships, and third-party technical integrations in employer-led health insurance products.
Former Chief Commercial Officer breaks down competitive dynamics of the obesity drug market, payer pushback, and what the next wave of competition means for Novo and Lilly margins.